Ikarian Capital, LLC
DALLAS, TX · CIK 1778253 · 13F filing filed 2022-08-12
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$698.0m
- Staff8 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $564.0m gross assets
- Form ADV · 2026-05-20SEC adviser record
- Legal entityIKARIAN CAPITAL, LLC (US)
- Kindhedge funds, futures
- Others nearbyDallas, TX
As an employer
- Offices in1 country
- Private fundshedge 1
$241.2m
reported value
-26.6% vs Q1 2022
99positions
47.3%in top 10
18 new
13 added
40 reduced
74 sold out
vs Q1 2022
Options: 29 call positions ($218.0m notional), 11 put positions ($89.2m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CELLDEX THERAPEUTICS INC NEW CLDX | $14.5m6.01% | Unchanged |
| ESPERION THERAPEUTICS INC NE ESPR | $13.1m5.42% | New |
| HORIZON THERAPEUTICS PUB L HZNP | $12.8m5.29% | Added +50.0k |
| KARUNA THERAPEUTICS INC COM | $12.7m5.25% | Added +50.0k |
| KEZAR LIFE SCIENCES INC COM | $11.6m4.83% | Added +325.0k |
| VERTEX PHARMACEUTICALS INC VRTX | $11.3m4.67% | Added +15.0k |
| ALTIMMUNE INC ALT | $10.5m4.35% | New |
| UNITED THERAPEUTICS CORP DEL UTHR | $9.4m3.91% | New |
| BELLUS HEALTH INC NEW BLU | $9.4m3.90% | Added +105.0k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $8.9m3.70% | Added +60.0k |
| GOSSAMER BIO INC GOSS | $8.4m3.47% | Added +225.1k |
| MILESTONE PHARMACEUTICALS IN MIST | $8.2m3.40% | Reduced -549.3k |
| XENON PHARMACEUTICALS INC XENE | $7.3m3.02% | Unchanged |
| TRACON PHARMACEUTICALS INC COM NEW | $5.6m2.31% | Reduced -54.4k |
| BIOMARIN PHARMACEUTICAL INC BMRN | $5.0m2.06% | Added +10.0k |
| VAXCYTE INC PCVX | $4.9m2.04% | Reduced -90.0k |
| GALAPAGOS NV LKFT | $4.8m2.00% | Unchanged |
| AMYLYX PHARMACEUTICALS INC AMLX | $4.8m1.97% | Reduced -150.1k |
| SCPHARMACEUTICALS INC SCPH | $4.3m1.77% | Reduced -86.1k |
| HARMONY BIOSCIENCES HLDGS IN HRMY | $4.2m1.74% | New |
| PFIZER INC PFE | $4.2m1.74% | Unchanged |
| NEUROCRINE BIOSCIENCES INC NBIX | $3.8m1.56% | New |
| KRANESHARES TR KWEB | $3.3m1.36% | New |
| SATSUMA PHARMACEUTICALS INC STSA | $2.7m1.12% | Unchanged |
| INSMED INC INSM | $2.5m1.02% | New |
| VIKING THERAPEUTICS INC VKTX | $2.4m1.00% | Added +302.8k |
| COGENT BIOSCIENCES INC COGT | $2.3m0.94% | New |
| ADICET BIO INC COM | $2.1m0.87% | Reduced -364.1k |
| LYRA THERAPEUTICS INC LYRA | $2.0m0.81% | Reduced -75.0k |
| APELLIS PHARMACEUTICALS INC APLS | $1.9m0.79% | New |
| SAREPTA THERAPEUTICS INC SRPT | $1.9m0.78% | New |
| SERES THERAPEUTICS INC COM | $1.9m0.77% | Reduced -300.0k |
| ASTRIA THERAPEUTICS INC CATB | $1.8m0.74% | Added +499.9k |
| TERNS PHARMACEUTICALS INC COM | $1.7m0.72% | New |
| X4 PHARMACEUTICALS INC COM | $1.6m0.67% | Added +307.7k |
| ALDEYRA THERAPEUTICS INC ALDX | $1.5m0.62% | Unchanged |
| INTERCEPT PHARMACEUTICALS IN ICPT | $1.4m0.60% | Added +69.9k |
| DBV TECHNOLOGIES S A SPONSORED ADR | $1.4m0.58% | Unchanged |
| IMMATICS N.V IMTX | $1.4m0.57% | Reduced -624.2k |
| VASCULAR BIOGENICS LTD COM | $1.3m0.55% | Reduced -740 |
| AADI BIOSCIENCE INC WHWK | $1.3m0.53% | Added +204.0k |
| MERUS N V MRUS | $1.2m0.50% | Unchanged |
| CABALETTA BIO INC CABA | $1.0m0.41% | Reduced -75.6k |
| CHEMOMAB THERAPEUTICS LTD SPONSORED ADS | $992.0k0.41% | Unchanged |
| ARDELYX INC ARDX | $991.0k0.41% | New |
| ANEBULO PHARMACEUTICALS INC ANEB | $942.0k0.39% | Unchanged |
| FINCH THERAPEUTICS GROUP INC COM | $938.0k0.39% | Unchanged |
| CHIMERIX INC CMRX | $917.0k0.38% | Reduced -400.0k |
| AUTOLUS THERAPEUTICS PLC AUTL | $912.0k0.38% | Reduced -50.0k |
| ELEDON PHARMACEUTICALS INC ELDN | $884.0k0.37% | Unchanged |
| RIGEL PHARMACEUTICALS INC COM NEW | $794.0k0.33% | Reduced -1.4m |
| CLOVIS ONCOLOGY INC CLVS | $761.0k0.32% | Reduced -350.0k |
| AYALA PHARMACEUTICALS INC COM | $759.0k0.31% | Reduced -11.1k |
| PROTARA THERAPEUTICS INC TARA | $756.0k0.31% | Reduced -38.6k |
| AILERON THERAPEUTICS INC ALRN | $752.0k0.31% | Reduced -9.8k |
| GEMINI THERAPEUTICS INC COM | $749.0k0.31% | Unchanged |
| BRAINSTORM CELL THERAPEUTICS COM NEW | $698.0k0.29% | Reduced -50.7k |
| PARDES BIOSCIENCES INC COM | $687.0k0.28% | Reduced -100.0k |
| REATA PHARMACEUTICALS INC RETA | $632.0k0.26% | Reduced -66.1k |
| BELLICUM PHARMACEUTICALS INC BLCM | $617.0k0.26% | Unchanged |
| SYNAPTOGENIX INC COM NEW | $614.0k0.25% | Reduced -32.0k |
| RENOVACOR INC COM | $595.0k0.25% | Reduced -50.0k |
| CONNECT BIOPHARMA HLDGS LTD ADS | $591.0k0.25% | Unchanged |
| INHIBRX INC INBX | $561.0k0.23% | Reduced -108.5k |
| SYNLOGIC INC COM | $545.0k0.23% | Reduced -45.4k |
| EVOLUS INC EOLS | $529.0k0.22% | New |
| RENEO PHARMACEUTICALS INC COM | $491.0k0.20% | Unchanged |
| IVERIC BIO INC OPHT | $473.0k0.20% | Unchanged |
| CASI PHARMACEUTICALS INC CASI | $378.0k0.16% | New |
| NEXTCURE INC COM | $336.0k0.14% | Reduced -69.6k |
| WAVE LIFE SCIENCES LTD 96663EUR | $318.0k0.13% | Reduced -950.0k |
| ZAI LAB LTD ZLAB | $278.0k0.12% | Unchanged |
| VERASTEM INC COM | $265.0k0.11% | Reduced -450.0k |
| IMMUNOPRECISE ANTIBODIES LTD COM NEW | $237.0k0.10% | Reduced -16.2k |
| HEPION PHARMACEUTICALS INC COM | $235.0k0.10% | Reduced -171.9k |
| BIOGEN INC BIIB | $228.0k0.09% | Unchanged |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $217.0k0.09% | Reduced -135.1k |
| REGULUS THERAPEUTICS INC RGLS | $217.0k0.09% | New |
| IMMUNIC INC COM | $214.0k0.09% | New |
| VERONA PHARMA PLC VRNA | $200.0k0.08% | New |
| MEREO BIOPHARMA GROUP PLC MREO | $199.0k0.08% | Reduced -300.0k |
| YUMANITY THERAPEUTICS INC COM | $190.0k0.08% | Reduced -131.9k |
| ASLAN PHARMACEUTICALS LTD ADS | $185.0k0.08% | Unchanged |
| CLENE INC CLNN | $177.0k0.07% | Reduced -444.3k |
| MYMD PHARMACEUTICALS INC COM | $176.0k0.07% | Reduced -50.3k |
| MUSTANG BIO INC MBIO | $145.0k0.06% | Reduced -300.0k |
| TEMPEST THERAPEUTICS INC COM | $132.0k0.05% | Unchanged |
| STEALTH BIOTHERAPEUTICS CORP SPONSORED ADS | $127.0k0.05% | Unchanged |
| CYCLACEL PHARMACEUTICALS INC COM | $113.0k0.05% | Unchanged |
| LARIMAR THERAPEUTICS INC LRMR | $100.0k0.04% | Unchanged |
| INVENTIVA SA IVA | $93.0k0.04% | Unchanged |
| BRIGHT MINDS BIOSCIENCES INC COM | $86.0k0.04% | Unchanged |
| MIND MEDICINE MINDMED INC COM SUB VTG | $68.0k0.03% | Unchanged |
| OVID THERAPEUTICS INC OVID | $59.0k0.02% | Reduced -711.5k |
| ENVERIC BIOSCIENCES INC COM NEW | $48.0k0.02% | Reduced -200.0k |
| ALTAMIRA THERAPEUTICS LTD CYTOF | $36.0k0.01% | Reduced -245.0k |
| BAUDAX BIO INC COM NEW | $3.0k0.00% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $00.00% | New |
| OTONOMY INC OTIC | $00.00% | Reduced -218.4k |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| BICYCLE THERAPEUTICS PLC BCYC | $21.0m478.8k shares |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $9.3m202.2k shares |
| SAGE THERAPEUTICS INC SAGE | $8.3m249.9k shares |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $7.1m60.0k shares |
| SIERRA ONCOLOGY INC | $7.0m217.9k shares |
| AMGEN INC AMGN | $4.8m20.0k shares |
| INTELLIA THERAPEUTICS INC NTLA | $3.4m47.4k shares |
| SAVARA INC SVRA | $2.1m1.6m shares |
| KYMERA THERAPEUTICS INC KYMR | $2.1m50.0k shares |
| LIQUIDIA CORPORATION LQDA | $1.8m243.9k shares |
| GLOBAL BLOOD THERAPEUTICS IN GBT | $1.7m50.0k shares |
| MACROGENICS INC MGNX | $1.4m164.1k shares |
| NUVATION BIO INC NUVB | $1.1m213.3k shares |
| AURINIA PHARMACEUTICALS INC AUPH | $1.1m87.1k shares |
| PHATHOM PHARMACEUTICALS INC PHAT | $1.1m78.5k shares |
| CASI PHARMACEUTICALS INC CASI | $1.1m1.3m shares |
| ASCENDIS PHARMA A/S | $1.0m8.8k shares |
| MAXCYTE INC MXCT | $964.0k138.0k shares |
| CORVUS PHARMACEUTICALS INC CRVS | $837.0k510.1k shares |
| BCLS ACQUISITION CORP | $762.0k77.3k shares |
| PANBELA THERAPEUTICS INC | $750.0k356.0k shares |
| QUANTUM SI INC QSI | $736.0k157.4k shares |
| INFLARX NV IFRX | $639.0k349.5k shares |
| PLIANT THERAPEUTICS INC PLRX | $636.0k90.8k shares |
| VISTAGEN THERAPEUTICS INC VTGN | $633.0k511.2k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC ALNY · Call | $42.5m291.3k shares | Added |
| SPDR SER TR XBI · Put | $26.0m350.0k shares | New |
| AMGEN INC AMGN · Call | $24.3m100.0k shares | Unchanged |
| BIOGEN INC BIIB · Call | $22.9m112.2k shares | Unchanged |
| AXSOME THERAPEUTICS INC AXSM · Put | $19.2m500.0k shares | New |
| CELLDEX THERAPEUTICS INC NEW CLDX · Put | $16.6m616.7k shares | Added |
| CELLDEX THERAPEUTICS INC NEW CLDX · Call | $13.7m506.5k shares | Added |
| AXSOME THERAPEUTICS INC AXSM · Call | $13.4m350.0k shares | New |
| KARUNA THERAPEUTICS INC Put | $12.7m100.0k shares | New |
| KEZAR LIFE SCIENCES INC Call | $8.9m1.1m shares | Added |
| BIOMARIN PHARMACEUTICAL INC BMRN · Call | $8.8m106.7k shares | Reduced |
| SAGE THERAPEUTICS INC SAGE · Call | $8.1m250.0k shares | Unchanged |
| HORIZON THERAPEUTICS PUB L HZNP · Call | $8.0m100.0k shares | Reduced |
| SAREPTA THERAPEUTICS INC SRPT · Call | $7.5m100.0k shares | New |
| AMYLYX PHARMACEUTICALS INC AMLX · Call | $6.8m350.8k shares | Added |
| LANTHEUS HLDGS INC LNTH · Call | $6.6m100.0k shares | New |
| ALNYLAM PHARMACEUTICALS INC ALNY · Put | $5.8m39.9k shares | Reduced |
| RELMADA THERAPEUTICS INC RLMD · Call | $5.7m300.0k shares | New |
| APELLIS PHARMACEUTICALS INC APLS · Call | $5.6m123.2k shares | Reduced |
| RELMADA THERAPEUTICS INC RLMD · Put | $5.4m282.3k shares | New |
| REATA PHARMACEUTICALS INC RETA · Call | $4.9m162.0k shares | Added |
| INTERCEPT PHARMACEUTICALS IN ICPT · Call | $4.8m350.0k shares | New |
| ALTIMMUNE INC ALT · Call | $3.6m303.6k shares | New |
| VIRIDIAN THERAPEUTICS INC VRDN · Call | $3.5m300.0k shares | New |
| BLUEPRINT MEDICINES CORP BPMC · Call | $3.2m64.0k shares | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| NEXTCURE INC NXTC · 13G · filed 2026-08-14 | 10.0%≈ $804.3k |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 | 9.9%≈ $704.0k |
| TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 | 9.5%≈ $1.3m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 | 9.0%≈ $1.7m |
| PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 | 7.7%≈ $7.3m |
| CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 | 7.3% |
| CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 | 6.9% |
| LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 | 6.3% |